Advertisement

Design and Reporting Characteristics of Clinical Trials of Select Chronic and Recurrent Pediatric Pain Conditions: An Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks Systematic Review

Published:September 13, 2018DOI:https://doi.org/10.1016/j.jpain.2018.08.007

      Highlights

      • Reported primary outcome measures were highly variable between trials.
      • CONSORT adverse event reporting standards were met in <50% of the articles reviewed.
      • Reporting recommendations for chronic pediatric pain trials are provided.

      Abstract

      Fewer randomized clinical trials (RCTs) are conducted for chronic or recurrent pain in pediatric populations compared with adult populations; thus, data to support treatment efficacy in children are limited. This article evaluates the design features and reporting practices of RCTs for chronic and recurrent pain that are likely unique to, or particularly important in, a pediatric population to promote improvements in the evidence base for pediatric pain treatments. Areas covered include outcome measure selection and reporting and reporting of adverse events and challenges to recruitment and retention. A search of PubMed and EMBASE identified primary publications describing RCTs of treatments for select chronic and recurrent pain conditions in children or adolescents published between 2000 and 2017. Only 49% of articles identified a primary outcome measure. The primary outcome measure assessed pain intensity in 38% of the trials, specifically measure by verbal rating scale (13%), faces pain scale (11%), visual analogue scale (9%), or numeric rating scale (5%). All of the CONSORT harms reporting recommendations were fulfilled by <50% of the articles. Discussions of recruitment challenges occurred in 64% of articles that enrolled <90% of their target sample. However, discussions regarding retention challenges only occurred in 14% of trials in which withdrawal rates were >10%. The goal of this article is to promote comprehensive reporting of pediatric pain RCTs to improve the design of future trials, facilitate conduction of systematic reviews and meta-analyses, and better inform clinical practice.

      Perspective

      This review of chronic and recurrent pediatric pain trials demonstrates inadequacies in the reporting quality of key features specifically important to pediatric populations. It provides recommendations that address these shortcomings to promote continued efforts toward improving the quality of the design and publication of future pediatric clinical pain trials.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adams LM
        • Turk DC
        Psychosocial factors and central sensitivity syndromes.
        Curr Rheumatol Rev. 2015; 11: 96-108
        • Arnold LM
        • Bateman L
        • Palmer RH
        • Lin Y
        Preliminary experience using milnacipran in patients with juvenile fibromyalgia: Lessons from a clinical trial program.
        Pediatr Rheumatol Online J. 2015; 13: 27
        • Arnold LM
        • Schikler KN
        • Bateman L
        • Khan T
        • Pauer L
        • Bhadra-Brown P
        • Clair A
        • Chew ML
        • Scavone J
        • Pregabalin Adolescent Fibromyalgia Study G
        Safety and efficacy of pregabalin in adolescents with fibromyalgia: A randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.
        Pediatr Rheumatol Online J. 2016; 14: 46
        • Berde CB
        • Walco GA
        • Krane EJ
        • Anand KJ
        • Aranda JV
        • Craig KD
        • Dampier CD
        • Finkel JC
        • Grabois M
        • Johnston C
        • Lantos J
        • Lebel A
        • Maxwell LG
        • McGrath P
        • Oberlander TF
        • Schanberg LE
        • Stevens B
        • Taddio A
        • von Baeyer CL
        • Yaster M
        • Zempsky WT
        Pediatric analgesic clinical trial designs, measures, and extrapolation: Report of an FDA scientific workshop.
        Pediatrics. 2012; 129: 354-364
        • Bieri D
        • Reeve RA
        • Champion GD
        • Addicoat L
        • Ziegler JB
        The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties.
        Pain. 1990; 41: 139-150
        • Borusiak P
        • Biedermann H
        • Bosserhoff S
        • Opp J
        Lack of efficacy of manual therapy in children and adolescents with suspected cervicogenic headache: Results of a prospective, randomized, placebo-controlled, and blinded trial.
        Headache. 2010; 50: 224-230
        • Brousseau DC
        • Duffy SJ
        • Anderson AC
        • Linakis JG
        Treatment of pediatric migraine headaches: A randomized, double-blind trial of prochlorperazine versus ketorolac.
        Ann Emerg Med. 2004; 43: 256-262
        • Bursch B
        • Walco GA
        • Zeltzer L
        Clinical assessment and management of chronic pain and pain-associated disability syndrome.
        J Dev Behav Pediatr. 1998; 19: 45-53
        • Caldwell PH
        • Butow PN
        • Craig JC
        Pediatricians' attitudes toward randomized controlled trials involving children.
        J Pediatr. 2002; 141: 798-803
        • Caldwell PH
        • Murphy SB
        • Butow PN
        • Craig JC
        Clinical trials in children.
        Lancet. 2004; 364: 803-811
        • Conte PM
        • Walco GA
        • Kimura Y
        Temperament and stress response in children with juvenile primary fibromyalgia syndrome.
        Arthritis Rheum. 2003; 48: 2923-2930
        • Dworkin JD
        • McKeown A
        • Farrar JT
        • Gilron I
        • Hunsinger M
        • Kerns RD
        • McDermott MP
        • Rappaport BA
        • Turk DC
        • Dworkin RH
        • Gewandter JS
        Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic review.
        J Clin Epidemiol. 2016; 72: 56-65
        • Eccleston C
        • Malleson P
        Managing chronic pain in children and adolescents. We need to address the embarrassing lack of data for this common problem.
        BMJ. 2003; 326: 1408-1409
        • Gewandter JS
        • Eisenach JC
        • Gross RA
        • Jensen MP
        • Keefe FJ
        • Lee DA
        • Turk DC
        Checklist for the preparation and review of pain clinical trial publications: A pain-specific supplement to CONSORT.
        Pain Rep. 2017; 621 (e): 1-8
        • Gewandter JS
        • McDermott MP
        • McKeown A
        • Smith SM
        • Williams MR
        • Hunsinger M
        • Farrar J
        • Turk DC
        • Dworkin RH
        Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations.
        Pain. 2014; 155: 1871-1877
        • Gewandter JS
        • McKeown A
        • McDermott MP
        • Dworkin JD
        • Smith SM
        • Gross RA
        • Hunsinger M
        • Lin AH
        • Rappaport BA
        • Rice AS
        • Rowbotham MC
        • Williams MR
        • Turk DC
        • Dworkin RH
        Data interpretation in analgesic clinical trials with statistically nonsignificant primary analyses: An ACTTION systematic review.
        J Pain. 2015; 16: 3-10
        • Gewandter JS
        • Smith SM
        • McKeown A
        • Burke LB
        • Hertz SH
        • Hunsinger M
        • Katz NP
        • Lin AH
        • McDermott MP
        • Rappaport BA
        • Williams MR
        • Turk DC
        • Dworkin RH
        Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations.
        Pain. 2014; 155: 461-466
        • Gewandter JS
        • Smith SM
        • McKeown A
        • Edwards K
        • Narula A
        • Pawlowski JR
        • Rothstein D
        • Desjardins PJ
        • Dworkin SF
        • Gross RA
        • Ohrbach R
        • Rappaport BA
        • Sessle BJ
        • Turk DC
        • Dworkin RH
        Reporting of adverse events and statistical details of efficacy estimates in randomized clinical trials of pain in temporomandibular disorders: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review.
        JADA. 2015; 146: 246-254 e6
        • Gherpelli JL
        • Esposito SB
        A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents.
        Arq Neuropsiquiatr. 2005; 63: 559-563
        • Goodman JE
        • McGrath PJ
        The epidemiology of pain in children and adolescents: A review.
        Pain. 1991; 46: 247-264
        • Hunsinger M
        • Smith SM
        • Rothstein D
        • McKeown A
        • Parkhurst M
        • Hertz S
        • Katz NP
        • Lin AH
        • McDermott MP
        • Rappaport BA
        • Turk DC
        • Dworkin RH
        Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review.
        Pain. 2014; 155: 2253-2262
        • Ioannidis JP
        • Evans SJ
        • Gotzsche PC
        • O'Neill RT
        • Altman DG
        • Schulz K
        • Moher D
        Better reporting of harms in randomized trials: An extension of the CONSORT statement.
        Ann Intern Med. 2004; 141: 781-788
        • Joseph PD
        • Craig JC
        • Caldwell PH
        Clinical trials in children.
        Br J Clin Pharmacol. 2015; 79: 357-369
        • Kashikar-Zuck S
        • Ting TV
        • Arnold LM
        • Bean J
        • Powers SW
        • Graham TB
        • Passo MH
        • Schikler KN
        • Hashkes PJ
        • Spalding S
        • Lynch-Jordan AM
        • Banez G
        • Richards MM
        • Lovell DJ
        Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: A multisite, single-blind, randomized, controlled clinical trial.
        Arthritis Rheum. 2012; 64: 297-305
        • King S
        • Chambers CT
        • Huguet A
        • MacNevin RC
        • McGrath PJ
        • Parker L
        • MacDonald AJ
        The epidemiology of chronic pain in children and adolescents revisited: A systematic review.
        Pain. 2011; 152: 2729-3738
        • Korterink JJ
        • Ockeloen LE
        • Hilbink M
        • Benninga MA
        • Deckers-Kocken JM
        Yoga therapy for abdominal pain-related functional gastrointestinal disorders in children: A randomized controlled trial.
        J Pediatr Gastroenterol Nutr. 2016; 63: 481-487
        • Lanzi G
        • D'Arrigo S
        • Termine C
        • Rossi M
        • Ferrari-Ginevra O
        • Mongelli A
        • Millul A
        • Beghi E
        The effectiveness of hospitalization in the treatment of paediatric idiopathic headache patients.
        Psychopathology. 2007; 40: 1-7
        • MacLennan SC
        • Wade FM
        • Forrest KM
        • Ratanayake PD
        • Fagan E
        • Antony J
        High-dose riboflavin for migraine prophylaxis in children: A double-blind, randomized, placebo-controlled trial.
        J Child Neurol. 2008; 23: 1300-1304
        • McGrath PJ
        • Walco GA
        • Turk DC
        • Dworkin RH
        • Brown MT
        • Davidson K
        • Eccleston C
        • Finley GA
        • Goldschneider K
        • Haverkos L
        • Hertz SH
        • Ljungman G
        • Palermo T
        • Rappaport BA
        • Rhodes T
        • Schechter N
        • Scott J
        • Sethna N
        • Svensson OK
        • Stinson J
        • von Baeyer CL
        • Walker L
        • Weisman S
        • White RE
        • Zajicek A
        • Zeltzer L
        Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.
        J Pain. 2008; 9: 771-783
      1. Palermo TM, Kashikar-Zuck S, Friedrichsdorf SJ, Powers SW: Special considerations in conducting clinical trials of chronic pain management interventions in children and adolescents and their families. Pain Reports. ACTTION Special Issue on Clinical Trials of Pain Treatments. e659, 2018

        • Robins PM
        • Smith SM
        • Glutting JJ
        • Bishop CT
        A randomized controlled trial of a cognitive-behavioral family intervention for pediatric recurrent abdominal pain.
        J Pediatr Psychol. 2005; 30: 397-408
        • Saps M
        • Youssef N
        • Miranda A
        • Nurko S
        • Hyman P
        • Cocjin J
        • Di Lorenzo C
        Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.
        Gastroenterology. 2009; 137: 1261-1269
        • Schwaller F
        • Fitzgerald M
        The consequences of pain in early life: Injury-induced plasticity in developing pain pathways.
        Eur J Neurosci. 2014; 39: 344-352
        • Smith SM
        • Chang RD
        • Pereira A
        • Shah N
        • Gilron I
        • Katz NP
        • Lin AH
        • McDermott MP
        • Rappaport BA
        • Rowbotham MC
        • Sampaio C
        • Turk DC
        • Dworkin RH
        Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review.
        Pain. 2012; 153: 2415-2421
        • Smith SM
        • Wang AT
        • Katz NP
        • McDermott MP
        • Burke LB
        • Coplan P
        • Gilron I
        • Hertz SH
        • Lin AH
        • Rappaport BA
        • Rowbotham MC
        • Sampaio C
        • Sweeney M
        • Turk DC
        • Dworkin RH
        Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.
        Pain. 2013; 154: 997-1008
        • Smith SM
        • Wang AT
        • Pereira A
        • Chang RD
        • McKeown A
        • Greene K
        • Rowbotham MC
        • Burke LB
        • Coplan P
        • Gilron I
        • Hertz SH
        • Katz NP
        • Lin AH
        • McDermott MP
        • Papadopoulos EJ
        • Rappaport BA
        • Sweeney M
        • Turk DC
        • Dworkin RH
        Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations.
        Pain. 2013; 154: 2769-2774
        • Stevens J
        • Hayes J
        • Pakalnis A
        A randomized trial of telephone-based motivational interviewing for adolescent chronic headache with medication overuse.
        Cephalalgia. 2014; 34: 446-454
        • U.S. Health and Human Services FDA
        Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims.
        (Available at:) (Accessed May 8, 2018)
        • Woolf CJ
        Central sensitization: Implications for the diagnosis and treatment of pain.
        Pain. 2011; 152: S2-S15
        • Zeltzer LK
        • Anderson CT
        • Schechter NL
        Pediatric pain: Current status and new directions.
        Current Problems in Pediatrics. 1990; 20: 409-486
        • Zouikr I
        • Bartholomeusz MD
        • Hodgson DM
        Early life programming of pain: Focus on neuroimmune to endocrine communication.
        J Transl Med. 2016; 14: 123